Loading...
Market
Will the FDA authorize another OTC COVID-19 and flu test by end of 2024?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from the FDA
Story
FDA Authorizes First Over-the-Counter COVID-19 and Flu Test Outside Emergency Use
Oct 8, 2024, 04:22 PM
The FDA has granted marketing authorization for the first over-the-counter combination COVID-19 and flu test for use without a prescription. This at-home test, which uses a nasal swab sample, is designed for individuals experiencing respiratory symptoms and can deliver results for both COVID-19 and flu. The test is the first of its kind to be authorized outside of emergency use, joining other similar tests that were previously available only under emergency use authorization. The approval comes as flu season approaches, providing a valuable tool for families to manage respiratory illnesses at home.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
None • 25%
1 to 2 • 25%
3 to 4 • 25%
More than 4 • 25%
Yes • 50%
No • 50%
Mostly positive reviews • 25%
Mixed reviews • 25%
Mostly negative reviews • 25%
Insufficient data • 25%
Yes • 50%
No • 50%
Multiple new tests introduced • 25%
One new test introduced • 25%
No new tests introduced • 25%
Other outcome • 25%
New test leads market • 25%
Existing tests maintain dominance • 25%
Market share evenly distributed • 25%
Other outcome • 25%